SlideShare une entreprise Scribd logo
1  sur  9
Télécharger pour lire hors ligne
New Hepatitis C Guidelines
(AASLD, IDSA, IAS-USA)
Dr. Ahsan
MBBS,FCPS (Medicine)
Senior Registrar Medical Unit-1
• The Evidence based consensus
recommendations for the screening, treatment
and management of patients with HCV were
developed by a panel of 27 liver disease and
infectious disease specialists and a patient
advocate.
• Available Online on;

• www.hcvguidelines.org
Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir
Types of Recommendations
• "Recommended”: when regimen is favored for
most patients
• "Alternative" when optimal in a particular
subset of patients in that category.
• "Not Recommended" When a treatment is
clearly inferior or is deemed harmful, such
regimens should not be administered to
patients with HCV infection
IFN ineligible
IFN ineligible is defined as one or more of the below:
• Intolerance to IFN
• Autoimmune hepatitis and other autoimmune disorders
• Hypersensitivity to PEG or any of its components
• Decompensated hepatic disease
• History of depression, or clinical features consistent with
depression
• A baseline neutrophil count below 1500/μL, a baseline
platelet count below 90,000/μL or baseline hemoglobin
below 10 g/dL
• A history of preexisting cardiac disease
SOFOSBUVIR
• Sofosbuvir (Tab. Sovaldi 400mg) is a prodrug
of a nucleotide analogue inhibitor of the HCV
NS5B RNA-dependent RNA polymerase.
• NEUTRINO, COSMOS trial: Genotype 1,4
• VALENCE
, POSITRON, FISSION, FUSION, PROTON
, ELECTRON : Genotype 2,3
• Approved By FDA In DEC 2013.
SIMEPREVIR
• Simeprevir (150 mg daily), a specific inhibitor
of the HCV NS3/4A serine protease.
• COSMOS TRIAL: GENOTYPE 1
Genotype 3 Recommendations
• It is anticipated that safer and more effective
IFN-free regimens will be available by 2015.

Contenu connexe

Tendances

Hepatitis C - Recent advances
Hepatitis C - Recent advancesHepatitis C - Recent advances
Hepatitis C - Recent advancesSubhasish Deb
 
Harvoni and Hepatitis C revised
Harvoni and Hepatitis C revisedHarvoni and Hepatitis C revised
Harvoni and Hepatitis C revisedThomas Huang
 
Hepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and preventionHepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and preventionNada Sami
 
Who.hcv treatment guidelines 2016
Who.hcv treatment  guidelines 2016Who.hcv treatment  guidelines 2016
Who.hcv treatment guidelines 2016Buruh harian lepas
 
Best Practices in the Management of HCV. 2015
Best Practices in the Management of HCV. 2015Best Practices in the Management of HCV. 2015
Best Practices in the Management of HCV. 2015hivlifeinfo
 
Challenges in HCV Management
Challenges in HCV Management Challenges in HCV Management
Challenges in HCV Management drnkhokhar
 
Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019Chetan Ganteppanavar
 
Chronic hepatitis b
Chronic hepatitis bChronic hepatitis b
Chronic hepatitis bBSMMU
 
CHRONIC HEPATITIS B
CHRONIC HEPATITIS BCHRONIC HEPATITIS B
CHRONIC HEPATITIS BFarhad Safi
 

Tendances (20)

HBV EASL 2017
HBV EASL 2017HBV EASL 2017
HBV EASL 2017
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
 
Hepatitis C - Recent advances
Hepatitis C - Recent advancesHepatitis C - Recent advances
Hepatitis C - Recent advances
 
Harvoni and Hepatitis C revised
Harvoni and Hepatitis C revisedHarvoni and Hepatitis C revised
Harvoni and Hepatitis C revised
 
Hepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and preventionHepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and prevention
 
HCV guidance may_24_2018b
HCV guidance may_24_2018bHCV guidance may_24_2018b
HCV guidance may_24_2018b
 
HCV Story ---by Mohammed Hussien
HCV Story ---by Mohammed HussienHCV Story ---by Mohammed Hussien
HCV Story ---by Mohammed Hussien
 
Hcv 4 ttt
Hcv 4 tttHcv 4 ttt
Hcv 4 ttt
 
Who.hcv treatment guidelines 2016
Who.hcv treatment  guidelines 2016Who.hcv treatment  guidelines 2016
Who.hcv treatment guidelines 2016
 
Best Practices in the Management of HCV. 2015
Best Practices in the Management of HCV. 2015Best Practices in the Management of HCV. 2015
Best Practices in the Management of HCV. 2015
 
Challenges in HCV Management
Challenges in HCV Management Challenges in HCV Management
Challenges in HCV Management
 
Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019Hepatitis C : Complete Overview and Recent Updates 2019
Hepatitis C : Complete Overview and Recent Updates 2019
 
Treatment of HCV Genotype 4
Treatment of HCV Genotype 4Treatment of HCV Genotype 4
Treatment of HCV Genotype 4
 
Basics of Hepatitis C
Basics of Hepatitis CBasics of Hepatitis C
Basics of Hepatitis C
 
Chronic hepatitis b
Chronic hepatitis bChronic hepatitis b
Chronic hepatitis b
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
 
Hapetitus B Presentation
Hapetitus B PresentationHapetitus B Presentation
Hapetitus B Presentation
 
Chronic hepatitis B
Chronic hepatitis BChronic hepatitis B
Chronic hepatitis B
 
Spectrum of HCV infection
Spectrum of HCV infectionSpectrum of HCV infection
Spectrum of HCV infection
 
CHRONIC HEPATITIS B
CHRONIC HEPATITIS BCHRONIC HEPATITIS B
CHRONIC HEPATITIS B
 

Similaire à Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir

MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatmentMANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatmentNimzingLadep
 
impact of different clinical trials on recent hypertension guidelines
impact of different clinical trials on recent hypertension guidelinesimpact of different clinical trials on recent hypertension guidelines
impact of different clinical trials on recent hypertension guidelinesSupratip Kundu
 
lab investigations in OMFS
lab investigations in OMFSlab investigations in OMFS
lab investigations in OMFSbhanupriya149
 
Acute liver failure.pptx
Acute liver failure.pptxAcute liver failure.pptx
Acute liver failure.pptxCutiePie71
 
Aasld guidelines for diagnosis & treatment of chronic hepatitis b
Aasld guidelines for diagnosis & treatment of chronic hepatitis bAasld guidelines for diagnosis & treatment of chronic hepatitis b
Aasld guidelines for diagnosis & treatment of chronic hepatitis bsreejith246
 
Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case
 Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case
Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced caseDr. Sumit KUMAR
 
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptxmoneralwsaby
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitisAhmed Ghany
 
RECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINESRECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINESAshutosh Pakale
 
Management of Chronic Hepatitis B in Non-Pregnant adults
Management of Chronic Hepatitis B in Non-Pregnant adultsManagement of Chronic Hepatitis B in Non-Pregnant adults
Management of Chronic Hepatitis B in Non-Pregnant adultsWajahat Sher Dil Khan
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)FarragBahbah
 
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptxsubhankar16
 
Management of haemophilia
Management of haemophiliaManagement of haemophilia
Management of haemophiliaDr Pooja Hurkat
 

Similaire à Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir (20)

EASL guideline for hepatitis C
EASL guideline for hepatitis CEASL guideline for hepatitis C
EASL guideline for hepatitis C
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
 
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatmentMANAGEMENT OF CHRONIC HEPATITIS B INFECTION  2021 - from diagnosis to treatment
MANAGEMENT OF CHRONIC HEPATITIS B INFECTION 2021 - from diagnosis to treatment
 
impact of different clinical trials on recent hypertension guidelines
impact of different clinical trials on recent hypertension guidelinesimpact of different clinical trials on recent hypertension guidelines
impact of different clinical trials on recent hypertension guidelines
 
hepatorenal syndrome
hepatorenal syndromehepatorenal syndrome
hepatorenal syndrome
 
lab investigations in OMFS
lab investigations in OMFSlab investigations in OMFS
lab investigations in OMFS
 
Acute liver failure.pptx
Acute liver failure.pptxAcute liver failure.pptx
Acute liver failure.pptx
 
Aasld guidelines for diagnosis & treatment of chronic hepatitis b
Aasld guidelines for diagnosis & treatment of chronic hepatitis bAasld guidelines for diagnosis & treatment of chronic hepatitis b
Aasld guidelines for diagnosis & treatment of chronic hepatitis b
 
Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case
 Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case
Hepatocellular Carcinoma (HCC): Updated Treatment Approaches in advanced case
 
HCV infection.pptx
HCV infection.pptxHCV infection.pptx
HCV infection.pptx
 
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitis
 
RECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINESRECENT RETROVIRAL DISEAAE GUIDELINES
RECENT RETROVIRAL DISEAAE GUIDELINES
 
chronic hep.pptx
chronic hep.pptxchronic hep.pptx
chronic hep.pptx
 
Management of Chronic Hepatitis B in Non-Pregnant adults
Management of Chronic Hepatitis B in Non-Pregnant adultsManagement of Chronic Hepatitis B in Non-Pregnant adults
Management of Chronic Hepatitis B in Non-Pregnant adults
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)
 
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx2022 Guideline for the Management of Heart Failure Clinical Update.pptx
2022 Guideline for the Management of Heart Failure Clinical Update.pptx
 
Hepatitis c.2019
Hepatitis c.2019Hepatitis c.2019
Hepatitis c.2019
 
Management of haemophilia
Management of haemophiliaManagement of haemophilia
Management of haemophilia
 
Mattes noon conference
Mattes noon conferenceMattes noon conference
Mattes noon conference
 

Dernier

ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project reportNARMADAPETROLEUMGAS
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 

Dernier (20)

ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
blood bank management system project report
blood bank management system project reportblood bank management system project report
blood bank management system project report
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 

Hepatitis c new guidelines 2014 by aasld idsa sofosbuvir

  • 1. New Hepatitis C Guidelines (AASLD, IDSA, IAS-USA) Dr. Ahsan MBBS,FCPS (Medicine) Senior Registrar Medical Unit-1
  • 2. • The Evidence based consensus recommendations for the screening, treatment and management of patients with HCV were developed by a panel of 27 liver disease and infectious disease specialists and a patient advocate. • Available Online on; • www.hcvguidelines.org
  • 4. Types of Recommendations • "Recommended”: when regimen is favored for most patients • "Alternative" when optimal in a particular subset of patients in that category. • "Not Recommended" When a treatment is clearly inferior or is deemed harmful, such regimens should not be administered to patients with HCV infection
  • 5. IFN ineligible IFN ineligible is defined as one or more of the below: • Intolerance to IFN • Autoimmune hepatitis and other autoimmune disorders • Hypersensitivity to PEG or any of its components • Decompensated hepatic disease • History of depression, or clinical features consistent with depression • A baseline neutrophil count below 1500/μL, a baseline platelet count below 90,000/μL or baseline hemoglobin below 10 g/dL • A history of preexisting cardiac disease
  • 6. SOFOSBUVIR • Sofosbuvir (Tab. Sovaldi 400mg) is a prodrug of a nucleotide analogue inhibitor of the HCV NS5B RNA-dependent RNA polymerase. • NEUTRINO, COSMOS trial: Genotype 1,4 • VALENCE , POSITRON, FISSION, FUSION, PROTON , ELECTRON : Genotype 2,3 • Approved By FDA In DEC 2013.
  • 7. SIMEPREVIR • Simeprevir (150 mg daily), a specific inhibitor of the HCV NS3/4A serine protease. • COSMOS TRIAL: GENOTYPE 1
  • 9. • It is anticipated that safer and more effective IFN-free regimens will be available by 2015.